4//SEC Filing
Horn Patrick Taylor 4
Accession 0001209191-21-005154
CIK 0001322505other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 5:37 PM ET
Size
9.8 KB
Accession
0001209191-21-005154
Insider Transaction Report
Form 4
Horn Patrick Taylor
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-01-21+23,700→ 23,700 totalExercise: $34.88Exp: 2031-01-20→ Common Stock (23,700 underlying) - Award
Common Stock
2021-01-21+5,500→ 9,935 total - Sale
Common Stock
2021-01-22$34.62/sh−110$3,808→ 9,825 total
Footnotes (5)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 21, 2022, with the remainder vesting in equal installments every three months thereafter beginning on April 21, 2022 and ending on January 21, 2025.
- [F2]Represents 1,622 shares of common stock and 8,313 restricted stock units. Includes 150 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan on November 30, 2020.
- [F3]Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F4]Represents 1,825 shares of common stock and 8,000 restricted stock units.
- [F5]This option vests as to 25% of the shares on January 21, 2022, with the remainder vesting in equal installments every three months thereafter beginning on April 21, 2022 and ending on January 21, 2025.
Documents
Issuer
ALBIREO PHARMA, INC.
CIK 0001322505
Entity typeother
Related Parties
1- filerCIK 0001572002
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 5:37 PM ET
- Size
- 9.8 KB